Abstract
In the field of therapeutic recombinant proteins, monoclonal antibodies (mAbs) have achieved a rising success with more than 30 mAbs that have reached the market in the past 20 years. From a structural standpoint, one of the most important posttranslational modifications affecting antibodies is by far glycosylation. Furthermore, glycosylation of mAbs directly impacts on their biological activity and safety and therefore needs to be well characterized. Glycoprotein analysis requires high-resolution separation techniques that can provide detailed structural analysis able to discriminate between glycoforms of various abundances. This chapter describes a protocol for nanoLC-Chip-MS/MS analysis of a proteolytic digest of the heavy chain of a recombinant mAb. The use of graphitized carbon column instead of classical C18 reversed-phase material is shown to be well suited to detect low abundant glycoforms and to provide in one shot information regarding both the oligosaccharide structure and the amino acid sequence of its peptide moiety.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jefferis R (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21:11–16
Beck A, Wagner-Rousset E, Bussat MC, Lokteff M, Klinguer-Hamour C, Haeuw JF et al (2008) Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Curr Pharm Biotechnol 9:482–501
Raju TS, Scallon BJ (2006) Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain. Biochem Biophys Res Commun 341:797–803
Takahashi N, Ishii I, Ishihara H, Mori M, Tejima S, Jefferis R et al (1987) Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry 26:1137–1144
Jefferis R (2006) Criteria for selection of IgG isotype and glycoform of antibody therapeutics. BioProcess Int 4:40–43
Srebalus Barnes CA, Lim A (2007) Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. Mass Spectrom Rev 26:370–388
Dell A, Morris HR (2001) Glycoprotein structure determination by mass spectrometry. Science 291:2351–2356
Mechref Y, Novotny MV (2002) Structural investigations of glycoconjugates at high sensitivity. Chem Rev 102:321–369
Mechref Y, Novotny MV (2006) Miniaturized separation techniques in glycomic investigations. J Chromatogr B Analyt Technol Biomed Life Sci 841:65–78
Zamfir A, Vakhrushev S, Sterling A, Niebel HJ, Allen M, Peter-Katalinic J (2004) Fully automated chip-based mass spectrometry for complex carbohydrate system analysis. Anal Chem 76:2046–2054
Ninonuevo M, An H, Yin H, Killeen K, Grimm R, Ward R et al (2005) Nanoliquid chromatography-mass spectrometry of oligosaccharides employing graphitized carbon chromatography on microchip with a high-accuracy mass analyzer. Electrophoresis 26:3641–3649
Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, Clowers BH et al (2006) A strategy for annotating the human milk glycome. J Agric Food Chem 54:7471–7480
Beck A, Bussat MC, Zorn N, Robillard V, Klinguer-Hamour C, Chenu S et al (2005) Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. J Chromatogr B Analyt Technol Biomed Life Sci 819:203–218
Demelbauer UM, Zehl M, Plematl A, Allmaier G, Rizzi A (2004) Determination of glycopeptide structures by multistage mass spectrometry with low-energy collision-induced dissociation: comparison of electrospray ionization quadrupole ion trap and matrix-assisted laser desorption/ionization quadrupole ion trap reflectron time-of-flight approaches. Rapid Commun Mass Spectrom 18:1575–1582
Wuhrer M, Catalina MI, Deelder AM, Hokke CH (2007) Glycoproteomics based on tandem mass spectrometry of glycopeptides. J Chromatogr B Analyt Technol Biomed Life Sci 849:115–128
Domon B, Costello CE (1988) A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconjugate J 5:397–409
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Wagner-Rousset, E., Schaeffer-Reiss, C., Bednarczyk, A., Corvaïa, N., Van Dorsselaer, A., Beck, A. (2013). NanoLC Chips MS/MS for the Characterization of N-Glycopeptides Generated from Trypsin Digestion of a Monoclonal Antibody. In: Beck, A. (eds) Glycosylation Engineering of Biopharmaceuticals. Methods in Molecular Biology, vol 988. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-327-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-62703-327-5_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-326-8
Online ISBN: 978-1-62703-327-5
eBook Packages: Springer Protocols